Meropenem

Part of speech: noun

Definitions

  1. A broad-spectrum antibiotic used to treat serious bacterial infections by inhibiting cell wall synthesis; typically administered intravenously for severe cases; effective against multiple resistant bacteria
  2. A potent beta-lactam antibiotic designed to combat severe bacterial illnesses by disrupting bacterial cell walls; given mainly through injection; covers a wide variety of pathogens including resistant strains
  3. An advanced antibiotic medication used intravenously to fight severe infections by preventing bacterial cell wall formation; used against a wide range of resistant bacteria in hospital settings

Etymology: The name meropenem belongs to a class of antibiotics known as carbapenems, which are crucial in treating serious bacterial infections resistant to many other drugs. This particular term was coined in the late 20th century, reflecting the modern practice of creating pharmaceutical names that hint at their chemical nature and therapeutic use. The prefix "mero-" in the name traces back to the Greek root "meros," meaning "part" or "segment," which in this context suggests a structural modification or derivative of an earlier compound. The suffix "-penem" identifies the molecule as belonging to the carbapenem family, a group of β-lactam antibiotics characterized by a unique ring structure that imparts strong antibacterial properties. This suffix itself derives from "penem," a variant of "penicillin," highlighting the chemical kinship to the penicillin family. Meropenem was developed to improve upon earlier carbapenems by enhancing stability against bacterial enzymes that degrade antibiotics and by broadening the spectrum of bacterial targets. Introduced in the late 1980s and early 1990s, its name was constructed to communicate both its lineage and its novel features, following conventions in pharmaceutical nomenclature where scientific roots and marketing clarity intersect. Thus, the word encapsulates a blend of classical language elements and modern scientific innovation, embodying a molecule designed to be a "part" of a larger strategy against resistant bacteria, anchored in the well-established legacy of penicillin-derived antibiotics.